26th Apr 2021 5:32 pm |
EQS |
Transaction in own shares |
23rd Apr 2021 5:11 pm |
EQS |
Transaction in own shares |
22nd Apr 2021 5:15 pm |
EQS |
Transaction in own shares |
21st Apr 2021 5:27 pm |
EQS |
Transaction in own shares |
20th Apr 2021 5:31 pm |
EQS |
Transaction in own shares |
19th Apr 2021 5:09 pm |
EQS |
Transaction in own shares |
16th Apr 2021 5:18 pm |
EQS |
Transaction in own shares |
15th Apr 2021 5:09 pm |
EQS |
Transaction in own shares |
14th Apr 2021 5:13 pm |
EQS |
Transaction in own shares |
13th Apr 2021 5:13 pm |
EQS |
Transaction in own shares |
12th Apr 2021 5:23 pm |
EQS |
Transaction in own shares |
9th Apr 2021 5:44 pm |
EQS |
Transaction in own shares |
8th Apr 2021 5:28 pm |
EQS |
Transaction in own shares |
8th Apr 2021 8:19 am |
RNS |
Proactive One2One Virtual Investor Forum |
8th Apr 2021 7:00 am |
EQS |
Arix to Present at the Proactive One2One Virtual Investor Forum |
7th Apr 2021 5:47 pm |
EQS |
Transaction in own shares |
7th Apr 2021 7:00 am |
EQS |
Artios announces collaboration with Novartis to create next generation DDR cancer therapies |
6th Apr 2021 5:26 pm |
EQS |
Transaction in own shares |
1st Apr 2021 5:20 pm |
EQS |
Transaction in own shares |
1st Apr 2021 7:00 am |
EQS |
Total Voting Rights |
31st Mar 2021 5:39 pm |
EQS |
Transaction in own shares |
30th Mar 2021 5:09 pm |
EQS |
Transaction in own shares |
30th Mar 2021 1:02 pm |
EQS |
Arix leads $152 million Series B financing for Pyxis Oncology |
30th Mar 2021 7:00 am |
EQS |
Gita Dittmar appointed as Venture Partner |
29th Mar 2021 5:14 pm |
EQS |
Transaction in own shares |
29th Mar 2021 7:00 am |
EQS |
Board update |
26th Mar 2021 5:14 pm |
EQS |
Transaction in own shares |
25th Mar 2021 4:58 pm |
EQS |
Transaction in own shares |
24th Mar 2021 5:05 pm |
EQS |
Transaction in own shares |
24th Mar 2021 7:00 am |
EQS |
Strategy Implementation Review |
23rd Mar 2021 5:27 pm |
EQS |
Transaction in own shares |
22nd Mar 2021 5:57 pm |
EQS |
Transaction in own shares |
22nd Mar 2021 11:09 am |
EQS |
Aura Biosciences announces oversubscribed $80 million financing |
22nd Mar 2021 7:00 am |
EQS |
Share buyback programme of up to £25 million |
19th Mar 2021 4:00 pm |
EQS |
Holding(s) in Company |
15th Mar 2021 7:30 am |
EQS |
Hardman & Co Research: Arix Bioscience (ARIX): 32% IRR since inception in 2016 |
15th Mar 2021 7:00 am |
EQS |
Share buyback programme of up to £25 million |
10th Mar 2021 7:01 am |
EQS |
Response to Activist Shareholder Acacia |
9th Mar 2021 7:01 am |
EQS |
Arix founds new portfolio company Twelve Bio |
9th Mar 2021 7:01 am |
EQS |
Annual Results for the Twelve Months ended 31 December 2020 |